# Tafluprost

NDC: 50742-339
Generic name: Tafluprost
Labeler / Manufacturer: Ingenus Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20241218

FDA application: ANDA218002

## Active ingredients

- TAFLUPROST: .015 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50742-339"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50742-339
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d766054-d13f-462c-bf8a-6462e56ca097